KirchhofPBenussiSKotechaDAhlssonAAtarDCasadeiBet al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962.
2.
MagneJSalernoBMohtyDSerenaCRolleFPiccardoAet al. Echocardiography is useful to predict postoperative atrial fibrillation in patients undergoing isolated coronary bypass surgery: A prospective study. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 103–112.
3.
ZeymerUAnnemansLDanchinNPocockSNewsomeSVandeWerfFet al. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 120–128.
4.
McIntyreWFUmKJCheungCCBelley-CôtéEPDingwallODevereauxPJet al. Atrial fibrillation detected initially during acute medical illness: A systematic review. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 129–140.
5.
Pohjantähti-MaaroosHHyppöläHLekkalaMSinisaloEHeikkolaAHartikainenJ.Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 113–119.
6.
ClaeysMJBosmansJVeenstraLJorensPRaedtHDVrintsCJ.Determinants and Prognostic Implications of Persistent ST-Segment Elevation After Primary Angioplasty for Acute Myocardial Infarction. Circulation. 1999; 99(15):1972-1977.
7.
YellonDMHausenloyDJ.Myocardial Reperfusion Injury. N Engl J Med. 2007; 357(11): 1121-1135.
8.
van der WegKPrinzenFWGorgelsAP.Reperfusion cardiac arrhythmias and their relation to reperfusion-induced cell death. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 141–151.
9.
SulzgruberPSchnaubeltSKollerLGoliaschGNiederdöcklJSimonAet al. Cardiac arrest as an age-dependent prognosticator for long-term mortality after acute myocardial infarction: the potential impact of infarction size. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 152–159.
10.
IbanezBJamesSAgewallSAntunesMJBucciarelli-DucciCBuenoHet al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationThe Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119-177.
11.
NeumannJTSörensenNARübsamenNOjedaFSchäferSKellerTet al. Right bundle branch block in patients with suspected myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 160–165.
12.
SchenoneALChenKAndressKMilitelloMChoL.Sedation in the coronary intensive care unit: An adapted algorithm for critically ill cardiovascular patient. Eur Heart J Acute Cardiovasc Care. 2019: 8(2): 166–174.
13.
ZelnikerTARuffCTWiviottSDBlancJ-JCappatoRNordioFet al. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 175–184.
14.
KorjianSBraunwaldEDaaboulYVerheugtFBodeCTenderaMet al. Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial. Eur Heart J Acute Cardiovasc Care. 2019; 8(2): 185–192.